Furthermore, the expression patterns of ATP7A and ATP7B significantly affect the prognosis of glioma: high expression of ATP7A is associated with poor clinical prognosis, while low expression of ATP7B is also associated with poor prognosis. This evidence concerns the gene ATP7B and central nervous system cancer.